The AAO-HNS/F OTO Forum provides an intimate forum for leadership discussions and practice management tools, highlighting the current and future needs of private practice physicians caring for otolaryngologic patients. The program will thematically focus on all things private practice otolaryngology with the guideposts of networking, benchmarking, innovation, and healthcare trends. This program includes didactic and interactive sessions lead by their peers and subject matter experts.
By attending the AAO-HNS/F OTO Forum attendees will be able to:
- Engage in tactical and topical subjects on ways to expand your practice.
- Discuss strategies on how to implement operational efficiencies to innovate, automate, or outsource.
- Keep up with the latest healthcare trends on payment reform and what lies ahead for your practice.
- Participate in thought-provoking sessions led by leaders in the field.
Target Audience
The OTO Forum is designed for otolaryngology-head and neck surgery residents, young physicians, and physician members.
Accreditation
This meeting has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. AAO-HNSF is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Claiming CME/MOC Credit
OTO Logic
AAO-HNSF designates this live activity for a maximum of 11.50 AMA PRA Category 1 Credits™. Participants should only claim credit commensurate with the extent of their participation. The OTOLogic team will be emailing you a link to complete your evaluation to claim your CME/MOC credit.
Deadline to claim credit is May 6, 2024.
Credit Hours
AAO-HNSF designates this live activity for a maximum of 11.50 AMA PRA Category 1 CreditsTM. Participants should only claim credit commensurate with the extent of their participation. Credit will be awarded to physicians when documented by the submission of the evaluation in www.OTOLogic.org.
The following sessions are approved for CME and will also count for MOC.
| Friday, April 5 | |
|
0.75 |
|
1.25 |
|
1.25 |
|
1.25 |
|
1.25 |
| Saturday, April 6 | |
|
0.75 |
|
1.25 |
|
1.25 |
|
1.25 |
|
1.25 |
Presenter Disclosure of Relevant Financial Relationships
The AAO-HNSF is committed to creating high-quality education that is independent of industry influence. All persons who have been in control of this educational content for this accredited CE activity has been asked to disclose all financial relationships with any ineligible companies they have had over the past 24 months (see below for definitions).
| Ineligible company: Any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition. |
| Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. |
| Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship. |
The ACCME also requires that AAO-HNSF manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
| Disclosures | Nothing to Disclose | Disclosure | ||
| Company | Role | Received | ||
| Planning Committee | ||||
| James C. Denneny III, MD | X | |||
| David E. Mellon, MD | X | |||
| Tirza Lofgreen, CHCP | X | |||
| Beth Burchill, CMP | X | |||
| Faculty | ||||
| Bill Blythe, MD | X | |||
| Tom Blum, PhD, HMA, MBA | X | |||
| Drew Brown | ||||
| Eugene (Gene) Brown, III, MD | X | |||
| G. Lee Bryant, Jr., MD | X | |||
| Steven P. Cragle, MD | X | |||
| Rose DuLude, PhD | ||||
| Julie Farley, COPM | X | |||
| Scott Fortune, MD | Acclarent Stryker ENT | Consultant | Consulting Fee | |
| David Godin, MD | ||||
| Dan Gold, MD | X | |||
| Eli Groppo, MD | X | |||
| Will Harrill, MD | X | |||
| Dave Hinkle | ||||
| Ron Howrigon | X | |||
| Andrew Johnson, MD | ||||
| Steven Kmucha, MD, JD | X | |||
| Dana Lichtenberg | ||||
| Carlos Lopez | ||||
| Keith Lynn | ||||
| Caleb Matterson, MD | ||||
| David E. Melon, MD | X | |||
| Mary T. Mitskavich, MD | X | |||
| Bobby Mukkamala, MD | X | |||
| Frank Opelka, MD | ||||
| Annette M. Pham, MBBS | X | |||
| Nora Perkins, MD | Stryker | Consultant | Consulting Fee | |
| Bob Puchalski, MD | X | |||
| Douglas Reh, MD | Optinose Sound Health NeurEnt | Honoraria Consulting Fee Consulting Fee |
||
| Gavin Setzen, MD | SUNY Albany, CRYOSA, Carelon Medical Benefits Management, Polyganics, Inc., ioTech International Stryker ENT Frequency Therapeutics | Intellectual Property Rights, Research Funding, Consulting Fee, and Stock | ||
| Hardy Shah | ||||
| Afser Shariff, MD | X | |||
| Abe Sheffield, MD | ||||
| Paul B. Swanson, MD | X | |||
| Kevin Watson, COPM | X | |||
| Jeffrey S. Weingarten, MD | Medical Hearing Consultants | Founder and President Consultant | Consulting Fee |
|
| Camile White, COPM | ||||
Clinical Medicine Recommendations/Scientific Research Reporting
The AAO-HNS informs all presenters and expects that:
- All recommendations involving clinical medicine in a professional education activity must be based on evidence that is accepted within the profession of medicine as adequate justification for the indications and contradictions in the care of patients; and
- All scientific research referred to, reported, or used in professional education in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Free Exchange of Medical Education Statement
AAO-HNSF is committed to the free exchange of medical education. Inclusion of any presentation or exhibit in this activity, including presentations or exhibits on drugs or medical devices, or the uses of drugs or medical devices that have not been approved by the FDA, does not imply an endorsement by the AAO-HNSF of the uses, products, or techniques presented.
The information contained in this activity represents the views of those who created it and does not necessarily represent the official view or recommendations of AAO-HNSF.
Deadline to claim credit is May 6, 2024.
Need assistance? Contact us at [email protected].
